Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Autolus Therapeutics PLC (ADR) - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
AUTL
Nasdaq
8731
https://www.autolus.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Autolus Therapeutics PLC (ADR)
Q4 2023 BioNTech SE Earnings Call
- Mar 21st, 2024 5:43 am
Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2023 Earnings Call Transcript
- Mar 17th, 2024 1:19 pm
Autolus Therapeutics Full Year 2023 Earnings: EPS Misses Expectations
- Mar 15th, 2024 11:35 am
Q4 2023 Autolus Therapeutics PLC Earnings Call
- Mar 15th, 2024 9:53 am
Autolus Therapeutics PLC Reports Full Year 2023 Financial Results
- Mar 14th, 2024 5:51 pm
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
- Mar 14th, 2024 11:00 am
Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certification for Nucleus commercial manufacturing site
- Mar 12th, 2024 11:00 am
Autolus Therapeutics announces publication in Blood Cancer Journal
- Mar 11th, 2024 11:00 am
Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024
- Feb 29th, 2024 12:00 pm
Autolus Therapeutics announces publication in Nature Communications
- Feb 22nd, 2024 12:00 pm
Autolus Therapeutics plc's (NASDAQ:AUTL) institutional investors lost 8.1% last week but have benefitted from longer-term gains
- Feb 21st, 2024 10:27 am
Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year?
- Feb 15th, 2024 2:40 pm
Strength Seen in Autolus Therapeutics PLC Sponsored ADR (AUTL): Can Its 6.3% Jump Turn into More Strength?
- Feb 12th, 2024 7:29 am
Autolus Announces Pricing of Underwritten Offering
- Feb 8th, 2024 12:00 pm
BioNTech partners with Autolus to boost cell therapy manufacturing
- Feb 8th, 2024 11:07 am
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
- Feb 8th, 2024 10:45 am
2seventy bio, Inc. (TSVT) Surges 28.2%: Is This an Indication of Further Gains?
- Feb 1st, 2024 1:27 pm
Autolus Therapeutics announces publication in ACS Chemical Biology
- Jan 23rd, 2024 12:00 pm
Autolus Therapeutics announces acceptance of Biologics License Application for obecabtagene autoleucel (obe-cel) as a potential treatment for relapsed/refractory Adult B-cell Acute Lymphoblastic Leukemia (ALL)
- Jan 22nd, 2024 12:00 pm
We're Not Very Worried About Autolus Therapeutics' (NASDAQ:AUTL) Cash Burn Rate
- Jan 11th, 2024 11:30 am
Scroll